DRAIN-EXSU: Impact of Peritoneal Gas Drain on Postoperative Pain for Gynaecological Cancer Patients With Minimally Invasive Surgery

Sponsor
Centre Oscar Lambret (Other)
Overall Status
Recruiting
CT.gov ID
NCT04974125
Collaborator
(none)
166
1
2
9.8
17

Study Details

Study Description

Brief Summary

This is a phase III, monocenter and randomized study, which evaluates the effectiveness of peritoneal gas drainage on postoperative pain in laparoscopic or robotic laparoscopic gynaecological surgery. This study aim is to assess the efficacy of active gas extraction with a drain (arm A) in comparison to manual evacuation (arm B,) in terms of pain incidence reduction linked to laparoscopic or robotic laparoscopic surgery.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Drain
  • Procedure: Manual exsufflation
N/A

Detailed Description

The primary objective is to assess the efficacy of active gas aspiration compared to simple manual gas evacuation to reduce the incidence of specific laparoscopic surgery pain.

Secondary objectives of this study include :
  • Comparing the evolution of specific pains after laparoscopic surgery, between study groups

  • Description of postoperative antalgics consumption in each group

  • Evaluating the safety of the evaluated procedure

  • Evaluating the impact of the evaluated procedure on hospitalisation duration ( for patients with ambulatory surgery initially planned)

Study Design

Study Type:
Interventional
Anticipated Enrollment :
166 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Patient will be pre-selected before medical operation. During the surgery, if the surgeon performs only the laparoscopy, the patient will be randomized. Then, the allocated procedure (with or without drain) will be carried out.Patient will be pre-selected before medical operation. During the surgery, if the surgeon performs only the laparoscopy, the patient will be randomized. Then, the allocated procedure (with or without drain) will be carried out.
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
Drain-Exsu: Phase III Trial Assessing the Effect of Peritoneal Gas Drain on Postoperative Pain in Gynecologic Minimally Invasive Surgery
Actual Study Start Date :
Jan 7, 2022
Anticipated Primary Completion Date :
Nov 1, 2022
Anticipated Study Completion Date :
Nov 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Arm A :Aspiration of peritoneal gas through a drain

Patients in experimental arm will receive surgery (either laparoscopic or robotised laparoscopic surgery). The exsufflation will be carrying out by a drain. Then, patients will be followed-up during 7 days after surgery.

Procedure: Drain
A 10 mm suction drain is placed through a trocar in the right hypochondrium (liver).

Active Comparator: Arm B : Manual evacuation of the peritoneal gas, via the trocar

Laparoscopic or robotised laparoscopic surgery + Trocar Patient in this experimental arm will receive surgery (either laparoscopic or robotised laparoscopic surgery). The exsufflation will be carrying out carried out manually using the trocar (standard of care).Then, patient will be followed-up during 7 days after surgery.

Procedure: Manual exsufflation
Exsufflation through the trocar opening.

Outcome Measures

Primary Outcome Measures

  1. Specific pain (shoulders and/or subcostal areas) related to the laparoscopic surgery (Day 0), measured with a numerical pain assessment scale (score from 0 to 10) [During the 24 hours after surgery]

    Comparison on portion of patients with significative early pain linked to the laparoscopic surgery, between the two groups (Chi-2 tests).

Secondary Outcome Measures

  1. Maximal score pain, measured with a numerical pain assessment scale (score from 0 to 10) [24 hours after surgery]

    The maximum score pain will be evaluated by the mean difference between each group (Student or Mann-Whitney tests).

  2. Assess pain at trocar holes comparatively in the two groups [24 hours after surgery]

    The site of pain will be reported to describe pain overall, but also specifically in the shoulders and/or subcostal areas and pain at trocar holes. Pain will be measured with the numerical pain assessment scale (score from 0 to 10).

  3. Laparoscopic surgery specific pains, measured with a numerical pain assessment scale (score from 0 to 10) [7 days after surgery]

    A notebook filled in by the patient at home with a daily assessment of pain according to the numerical pain assessment scale, with a phone call from the nurse on day 7 (considering that the day of the surgery is day 0).

  4. Antalgics consumption [24 hours and 7 days after surgery]

    Qualitative description through patient notebook.

  5. Antalgics consumption [24 hours and 7 days after surgery]

    Quantitative description through patient notebook.

  6. Adverse events (AE) (grade ≥III Clavien-Dindo classification) [30 days after surgery]

    Safety procedure will be describe through adverse events notification potentially related to the procedure and their grade (total amount of AE, maximal grade of AE per patient).

  7. Evaluate the impact of the evaluated procedure on the hospitalisation duration [Through the study patient participation, an average of 2 months]

    Impact of the peritoneal gas aspiration technique on the hospitalisation duration for patient with ambulatory surgery.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age ≥ 18 ans ;

  • Woman who underwent laparoscopic or robotised laparoscopic surgery in peritoneal cavity (benign or malignant gynaecological affection) ;

  • Planned ambulatory surgery

  • Patient willing and able to be treated and followed according the protocol during the trial ;

  • Patient covered by the French "Social Security" regime ;

  • Effective contraception for reproductive age patients ;

  • Signed written informed consent before surgery

Per-operatory eligibility criterion :
  • No conversion from laparoscopic surgery to laparotomy surgery
Exclusion Criteria:
  • Extra-peritoneal surgery scheduled ( example : aortic dissection) ;

  • Upper-abdomen surgery (example : liver, gall bladder) ;

  • History of shoulders pains prior to surgery (the assessment must be carried out within a period of 30 days before the surgery) ;

  • Inability to comply with medical follow-up of the trial (geographical, social or psychic reasons)

  • Person under guardianship

  • Pregnant or breastfeeding woman

Non eligibility criterion known during the operation :
  • Conversion from laparoscopic surgery to laparotomy surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Fabrice NARDUCCI Lille France 59020

Sponsors and Collaborators

  • Centre Oscar Lambret

Investigators

  • Study Director: Fabrice NARDUCCI, PhD, Centre Oscar Lambret

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Oscar Lambret
ClinicalTrials.gov Identifier:
NCT04974125
Other Study ID Numbers:
  • DRAIN-EXSU-1907
First Posted:
Jul 23, 2021
Last Update Posted:
Feb 23, 2022
Last Verified:
Jul 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Centre Oscar Lambret
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 23, 2022